TerminatedNot Applicable

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Stopped: lack of enrollment

United States2 participantsStarted 2012-11

Plain-language summary

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with new diagnosis of CSC and no other comorbidities or prior retinal treatment * Patients ranging from 30 to 60 years of age Exclusion Criteria: * Patients with no case of CSC * Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration * Patients with prior retinal treatment

What they're measuring

Resolution of Fluid Build-up

Timeframe: within 1 week to 3 months after the laser procedure is completed

Trial details

NCT IDNCT01982383

SponsorGeorge Washington University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-11

Results submitted2018-03-01

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials